ArticleFrontiers in cellular and infection microbiology2025
The burden of infective encephalitis in children in Asian countries (1990-2021): systematic analysis and projection of the burden of disease.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pentoxifylline in children with acute encephalitis syndrome: a randomized control trial.European journal of pediatrics · 2026Trial
- Burden of 46 key pathogens among children in G20 countries, 2023: A systematic analysis and regional comparison.PLoS neglected tropical diseases · 2026Article
- Clinical and laboratory profiles of acute central nervous system infections in a Chinese pediatric cohort: a five-year retrospective analysis.BMC pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infective encephalitis (IE) constitutes a severe neurological disorder with considerable morbidity and mortality among children, particularly in Asia, where stark disparities in socioeconomic status and healthcare accessibility prevail. Despite its substantial impact, comprehensive epidemiological investigations into pediatric IE across Asia remain scarce. Objective: This study aimed to systematically evaluate the burden of pediatric IE in Asia from 1990 to 2021, examine its association with sociodemographic development, identify major risk factors, and forecast future trends. Methods: Utilizing data from the Global Burden of Disease (GBD) 2021 study, we retrieved incidence, mortality, and disability-adjusted life years (DALYs) for individuals aged 0-14 years across six Asian regions and more than 50 countries. Statistical methods included trend analysis via estimated annual percentage change (EAPC), Spearman's correlation between disease burden and the Sociodemographic Index (SDI), and decomposition of risk factors. A Bayesian Age-Period-Cohort (BAPC) model was employed to project trends in China, Japan, South Korea, and India from 2022 to 2035. Results: In 2021, Asia recorded 537,750 IE cases (49.3 per 100,000), 18,844 deaths (1.7 per 100,000), and 1.69 million DALYs (155.1 per 100,000). Between 1990 and 2021, there were substantial reductions in the burden of IE: incidence declined by 28.1% (from 68.6 to 49.3 per 100,000), mortality by 53.2% (from 3.7 to 1.7 per 100,000), and DALYs by 53.2% (from 331.0 to 155.1 per 100,000). South Asia exhibited the highest burden (71.7 incidence, 2.5 mortality, 226.7 DALYs per 100,000), whereas the High-income Asia Pacific region reported the lowest (11.7, 0.1, 11.6 per 100,000). SDI demonstrated strong inverse correlations with incidence (r = -0.73), mortality (r = -0.87), and DALYs (r = -0.87). Low birth weight/prematurity and particulate matter pollution emerged as principal risk factors. Forecasts suggest continued declines by 2035, with India and China projected to see the most pronounced reductions in incidence (-62.4% and -41.3%, respectively). Conclusion: Although the burden of IE has markedly declined since 1990, it remains a pressing public health concern in low-SDI Asian regions. Focused strategies addressing undernutrition, environmental hazards, and neonatal health are imperative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.